FindTrial
Sign In

A study on Irritable Bowel Syndrome treatment using Boger Boenninghausens characteristics and repertory.

The Clinical Utility Of Boger Boenninghausens Characteristics and Repertory in the Management of Irritable Bowel Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095821
Enrollment
30
Registered
2025-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K58- Irritable bowel syndrome

Interventions

Intervention1: Individualised Homoeopathic medicine: Homoeopathic Medicine selected based on symptom similarity will be administered to the patients in proper dose potency and repetition of medicine

Sponsors

Department of Homoeopathic Repertory and Case Taking,White Memorial Homoeopathy Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group from 35 to 50 years. Sex: Male & Female All cases that fit into ROME 1V diagnostic criteria.

Exclusion criteria

Exclusion criteria: Cases that do not satisfy the ROME IV criteria. Patient who are already under treatment for Gastrointestinal disorders. Pregnant and lactation women. Patients suffering from other systemic illness who are under medication.

Design outcomes

Primary

MeasureTime frame
Assessment of Improvement will be done by IBS-SSS Before and after treatment.Outcome will be classified as follows: MARKED IMPROVEMENT: More than 75% score MODERATE IMPROVEMENT: 40-75% MILD IMPROVEMENT: 5-40% NO IMPROVEMENT:Less than 5% Timepoint: 6 months—

Secondary

MeasureTime frame
TO understanding The utility of Boger Boenninghusens Characteristics and Repertory.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDR R K DOMININ RAJ

White Memorial Homoeopathy Medical College, Attoor

drdomininrajrk@gmail.com9447654467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026